Anavex Life Sciences Corp (AVXL)

[XenaLives]

Compiled: IP protection 08/08/19
___________________________________________________________________________________
Patent update re: AV1066.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149346961

AVXL patent on AI to treat Alzheimer's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150169367

IP.....good article on Intellectual Property in the BioPharma sector
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150118360

Greenspam3 links to new patent applications for visceral and neuropathic pain and also regulation of blood pressure:

https://patentscope.wipo.int/search/en/detail.jsf?docId=US243292967&recNum=1&office&queryString=FP%3A%28anavex%29&prevFilter&sortOption=Pub+Date+Desc&maxRec=38&fbclid=IwAR0iQoR01ea7s1UHVBUfMZG9_2CFKNXSiBIZHsMoQ7R7qQBMIbF_crtkokE

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2019108653&tab=PCTBIBLIO&office&prevFilter&sortOption=Pub+Date+Desc&queryString=FP%3A%28anavex%29&recNum=2&maxRec=38&fbclid=IwAR1R-6LmOI1qaWSmh1gixjbLF6qLMAuhqT2mS-DT173ea-5uiJId_DNz6iA

Beginning of discussion for above:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149304398

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQB: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, is pleased to announce that it has been issued U.S. Patent No. 8,673,931 (the “Patent”). The composition and method Patent covers ANAVEX 3-71 (formerly AF710B) for treating Alzheimer’s disease (AD), type 2 diabetes and insulin resistance. (posted by georgejjl)
https://www.anavex.com/anavex-awarded-new-u-s-patent/

United States Patent Application January 24, 2019
NEURODEVELOPMENTAL DISORDER THERAPY
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148757220

Patent filing released 04/25/19: Anavex 2-73 for the Treatment of Cardiac Dysfunction
(from TTTav66)
https://patentscope.wipo.int/search/de/detail.jsf?docId=US241444653
Discussion here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148457849
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148470928

Patent - ANAVEX2-73 in a method of treatment for neurodevelopmental disorders:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148472474

AV1066 for pain an approved patent which is "ready for issue" as of 12/28/18
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145909839

Patent for specific crystaline forms of 2-73 provides extended IP protection:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145420021

Patent for Insomnia: (EN) A2-73 AS A THERAPEUIC FOR INSOMNIA, ANXIETY, AND AGITATION
Abstract:
(EN)A2-73 is a useful therapeutic in the treatment of humans suffering from insomnia, anxiety or agitation. Particular attention is made to oral daily doses of from about 10mg to about 50mg, with particular reference to about 20 to 30mg. (from basparks79)
https://patentscope.wipo.int/search/en/detail.jsf;jsessionid=173B4DDABFF25B0C26F75F5B8E98D703.wapp2nA?docId=WO2018022848&recNum=1&maxRec=13&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28anavex%29&tab=PCT+Biblio

More on the patent for Insomnia:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144833903
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144834373
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144842204

Anavex, Cognision, and Ariana are doing ground breaking research in Alzheimer's disease:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145774113

December 20, 2018 Anavex & Cognision U.S. Patent Application, intermittent dosage :
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145735301
more info on Cognision in the partners post

The following posts relate to the above patent:
Tool suite used in the above patent (thanks Nidan7500):
https://www.dadm.alzdem.com/article/S2352-8729(15)00070-6/fulltext
https://www.advancedbrainmonitoring.com/

Summary of Checci patent Application:
https://investorshub.advfn.com/boards/read_msg.aspx?

ERP patent app with related organizations:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147781853
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147788179
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147668300
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147844189
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147990271

Additional info in Anavex partners post linked at the bottom of the primary post.